Jay Bhattacharya frames replication as an honor that signals a paper’s significance and trustworthiness, not a threat to researchers.

Replication is essential in science to reduce false positives, and even correct studies can yield Type 1 errors due to statistical limits.

NIH’s replication funding plans have expanded from modest $850,000 prizes to a broader $174 million program to address concerns that replication is unfair or too costly for individual scientists.

Incentives and human behavior make replication financially and practically necessary to determine which findings are robust.

While costs matter, replication can be made efficient by leveraging information from existing studies to guide sample sizes and power.

The overall conclusion is clear: invest in replication to obtain more precise, reliable knowledge and advance robust scientific progress.

Replication infrastructure should be viewed as an investment that reduces false positives and increases confidence, not as policing scientists for errors.

A 5% significance level yields a 0.25% chance that two independent studies both produce false positives; replication dramatically lowers this risk.